Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Taysha Gene Therapies Inc (NQ: TSHA )

2.720 +0.250 (+10.12%)
Streaming Delayed Price Updated: 10:37 AM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Taysha Gene Therapies Inc

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Celldex Therapeutics (NASDAQ:CLDX) stock increased by 21.35% to $39.33 during Monday's regular session. Celldex Therapeutics's stock is trading at a volume... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Galectin Therapeutics (NASDAQ:GALT) shares moved upwards by 35.0% to $3.73 during Friday's regular session. As of 12:30 EST, Galectin Therapeutics's stock... 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Thursday morning, 158 companies reached new 52-week lows. Noteworthy Highlights: The largest company in terms of market cap to set a new 52-week low was Alibaba... 
Via Benzinga
What 9 Analyst Ratings Have To Say About Taysha Gene Therapies
Taysha Gene Therapies (NASDAQ:TSHA) has observed the follo... 
Via Benzinga
Earnings Scheduled For May 11, 2021
Companies Reporting Before The Bell • Oxford Lane Capital (NASDAQ:OXLC) is estimated to report earnings for its fourth quarter. • ReWalk Robotics (NASDAQ:RWLK) is... 
Via Benzinga
The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8) Aerpio Pharmaceuticals, Inc... 
Via Benzinga
Taysha Gene Therapies to Participate in Upcoming July Investor Healthcare Conference
From Taysha Gene Therapies, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Alterity Therapeutics (NASDAQ:ATHE 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Osmotica Pharmaceuticals (NASDAQ:OSMT) stock increased by 39.78% to $3.97 during Friday's regular session. The current volume of 48.4 million shares is 18988.... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 24, 2021
Upgrades Zelman upgraded the previous rating for Armstrong World Industries Inc (NYSE: 
Via Benzinga
Taysha Gene Therapies Announces Publication of Natural History Data for TSHA-120 in Giant Axonal Neuropathy in the Journal, Brain
From Taysha Gene Therapies, Inc.
Via Business Wire
Taysha Gene Therapies to Host Virtual R&D Day
From Taysha Gene Therapies, Inc.
Via Business Wire
Analyst Ratings for Taysha Gene Therapies
Taysha Gene Therapies (NASDAQ:TSHA) has observed the following analyst ratings within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 1 0 0 1... 
Via Benzinga
Taysha Gene Therapies to Participate in Upcoming Investor Healthcare Conference and CEO Forum
From Taysha Gene Therapies, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2021
Upgrades According to Raymond James, the prior rating for Welltower Inc (NYSE:WELL) was changed from Market Perform to Strong Buy. For the first quarter, Welltower had an... 
Via Benzinga
Taysha Gene Therapies to Host First Annual Stockholder Meeting
From Taysha Gene Therapies, Inc.
Via Business Wire
Expert Ratings for Taysha Gene Therapies
Taysha Gene Therapies (NASDAQ:TSHA) has observed the following analyst ratings within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 0 0 1 0... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 9, 2021
Upgrades According to Deutsche Bank, the prior rating for KLA Corp (NASDAQ:KLAC) was changed from Hold to Buy. KLA earned $3.85 in the third quarter, compared to $2.47 in... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 8, 2021
Upgrades According to Seaport Global, the prior rating for CMC Materials Inc (NASDAQ:CCMP) was changed from Neutral to Buy. CMC Materials earned $1.71 in the second... 
Via Benzinga
Taysha Gene Therapies to Participate in Upcoming June Investor Healthcare Conferences
From Taysha Gene Therapies, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For May 19, 2021
Upgrades For Agilysys Inc (NASDAQ:AGYS), Craig-Hallum upgraded the previous rating of Hold to Buy. Agilysys earned $0.21 in the fourth quarter, compared to $0.05 in the... 
Via Benzinga
Taysha Gene Therapies Joins the Rare Disease Company Coalition
From Taysha Gene Therapies, Inc.
Via Business Wire
Taysha Gene Therapies Expands Leadership Team with the Appointment of Chief Development Officer
From Taysha Gene Therapies, Inc.
Via Business Wire
Taysha Gene Therapies to Participate in Upcoming May Investor Healthcare Conferences
From Taysha Gene Therapies, Inc.
Via Business Wire
Taysha Gene Therapies, Inc. (TSHA) Q1 2021 Earnings Call Transcript
TSHA earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Taysha Gene Therapies Reports First Quarter 2021 Financial Results and Provides a Corporate Update
From Taysha Gene Therapies, Inc.
Via Business Wire
The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -... 
Via Benzinga
Exposures COVID-19 Product Safety
Taysha Gene Therapies' Rett Syndrome Candidate Shows Encouraging Action In Animal Studies, Human Trial To Start By 2021
Taysha Gene Therapies Inc (NASDAQ: TSHA) has announced the online publication of new preclinical data for TSHA-102 in Rett syndrome. The data will be included in... 
Via Benzinga
Taysha Gene Therapies Announces Publication of Preclinical Data for TSHA-102 in Rett Syndrome in Brain, a Highly Esteemed Neurological Science Peer-Reviewed Journal
From Taysha Gene Therapies, Inc.
Via Business Wire
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... 
Via Benzinga
Exposures COVID-19 Product Safety
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.